Regulatory B-cell states in NSCLC immunotherapy resistance: mechanisms, spatial context and translational implications.

Authors

Xin Wang, Xi Li, Jing Zhou, Kai Yang, Rong Hu, Bin Pan

Published in

Cancer immunology, immunotherapy : CII. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Although immune checkpoint inhibitors (ICIs) have improved clinical outcomes, durable benefit is limited by primary and acquired resistance arising from dynamic interactions between tumour cells and the tumour microenvironment. While current models remain largely T cell-centred, accumulating evidence indicates that B-cell states also shape therapeutic response. Here, we propose that regulatory B cells (Bregs) in NSCLC are best understood not as a fixed lineage, but as inducible Breg-associated states that may amplify immunotherapy resistance. We discuss how these states arise under tumour-driven conditions and are further shaped by spatial context, particularly within tertiary lymphoid structures (TLSs) and related immune niches. We further examine how Breg-associated states restrain antitumour immunity and interact with other immunosuppressive populations. This perspective reframes resistance beyond T cell-centric models and supports the development of biomarker-guided, functionally selective, and spatially informed therapeutic strategies.

PMID:
42362948
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.